Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant <i>Lomentospora prolificans</i> infection in a child

<i>Lomentospora prolificans</i> is a multi-drug-resistant filamentous fungus that can cause invasive disease in both immunocompromised and immunocompetent hosts. Current treatment options are limited. Olorofim is an investigational antifungal that demonstrates activity against several different molds, including many that are resistant to other antifungals. The case presented by Fortini et al. (Antimicrob Agents Chemother 69:e00602-25, 2025, https://doi.org/10.1128/aac.00602-25) describes the successful use of olorofim treatment in an 8-year-old who suffered from <i>Lomentospora prolificans</i> tendonitis, synovitis, and osteomyelitis.

Authors

Institutions

Publication Details

Journal
Antimicrobial Agents and Chemotherapy
Published
2025-09-26
DOI
https://doi.org/10.1128/aac.01072-25
Citations
1
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child

Nathan P. Wiederhold
1 citations
Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibility
1.40
article

Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child

Nathan P. Wiederhold
article en
1 citations

Abstract

<i>Lomentospora prolificans</i> is a multi-drug-resistant filamentous fungus that can cause invasive disease in both immunocompromised and immunocompetent hosts. Current treatment options are limited. Olorofim is an investigational antifungal that demonstrates activity against several different molds, including many that are resistant to other antifungals. The case presented by Fortini et al. (Antimicrob Agents Chemother 69:e00602-25, 2025, https://doi.org/10.1128/aac.00602-25) describes the successful use of olorofim treatment in an 8-year-old who suffered from <i>Lomentospora prolificans</i> tendonitis, synovitis, and osteomyelitis.

Antimicrobial Agents and ChemotherapyVol. 69(11)
The University of Texas at San Antonio Health Science Center (US), The University of Texas at San Antonio (US)
Openalex Percentile: Top 16%
Antifungal resistance and susceptibility
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.